Tazemetostat Disease Interactions
There is 1 disease interaction with tazemetostat.
Tazemetostat (applies to tazemetostat) hepatic impairment
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Liver Disease
Tazemetostat has not been studied in patients with moderate or severe hepatic impairment. Care should be exercised when using this drug in these patients. No dose adjustment is needed for patients with mild hepatic impairment.
Switch to professional interaction data
Tazemetostat drug interactions
There are 566 drug interactions with tazemetostat.
Tazemetostat alcohol/food interactions
There is 1 alcohol/food interaction with tazemetostat.
More about tazemetostat
- tazemetostat consumer information
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Epkinly
Epkinly is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) ...
Brukinsa
Brukinsa is used to treat adults with mantle cell lymphoma, Waldenström’s macroglobulinemia, ma ...
Truxima
Truxima is used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid ...
Gazyva
Gazyva is used to treat chronic lymphocytic leukemia (CLL) or follicular lymphoma (FL) in adults ...
Ruxience
Ruxience is a biosimilar to Rituxan and is used to treat certain leukemias and lymphomas and some ...
Tazverik
Tazverik (tazemetostat) used for the treatment of patients with epithelioid sarcoma and follicular ...
Interferon alfa-2b
Interferon alfa-2b systemic is used for angioblastoma, condylomata acuminata, conjunctival ...
Obinutuzumab
Obinutuzumab is used to treat chronic lymphocytic leukemia (CLL) or follicular lymphoma (FL) in ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.